MedTrace Logo

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

NCT01264822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2017-02-27

No results posted yet for this study

Summary

To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori

Conditions

  • Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive

Interventions

DRUG

Rabeprazole Sodium

The following 3 drugs are taken orally at the same time twice daily for 7 days: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and clarithromycin 200 mg. The dose of clarithromycin may be properly increased as needed, although the upper limit is 400 mg twice daily. If Helicobacter pylori eradication with proton pump inhibitor, amoxicillin, and clarithromycin fails, the following 3 drugs will be taken at the same time twice daily for 7 days as an alternative treatment for adults: rabeprazole sodium 10 mg, amoxicillin hydrate 750 mg, and metronidazole 250 mg.

Sponsors & Collaborators

  • Eisai Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Katsuya Sugizaki · Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-13
Primary Completion
2016-02-29
Completion
2016-11-17

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01264822 on ClinicalTrials.gov